GW&K Investment Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.3M | Sell |
1,378,432
-133,779
| -9% | -$1.88M | 0.17% | 205 |
|
|
2025
Q1 | $23.7M | Sell |
1,512,211
-31,873
| -2% | -$498K | 0.22% | 178 |
|
|
2024
Q4 | $21.5M | Sell |
1,544,084
-49,546
| -3% | -$690K | 0.18% | 197 |
|
|
2024
Q3 | $14.8M | Sell |
1,593,630
-74,349
| -4% | -$691K | 0.13% | 234 |
|
|
2024
Q2 | $15.5M | Sell |
1,667,979
-53,274
| -3% | -$495K | 0.14% | 220 |
|
|
2024
Q1 | $17.1M | Buy |
1,721,253
+80,928
| +5% | +$802K | 0.15% | 206 |
|
|
2023
Q4 | $5.3M | Sell |
1,640,325
-428,968
| -21% | -$1.39M | 0.05% | 264 |
|
|
2023
Q3 | $11M | Buy |
2,069,293
+6,610
| +0.3% | +$35.1K | 0.11% | 234 |
|
|
2023
Q2 | $19.7M | Buy |
2,062,683
+157,961
| +8% | +$1.51M | 0.19% | 187 |
|
|
2023
Q1 | $21M | Buy |
1,904,722
+352,708
| +23% | +$3.88M | 0.2% | 175 |
|
|
2022
Q4 | $23M | Buy |
1,552,014
+643,101
| +71% | +$9.52M | 0.23% | 162 |
|
|
2022
Q3 | $17.4M | Buy |
908,913
+232,235
| +34% | +$4.44M | 0.19% | 180 |
|
|
2022
Q2 | $14.4M | Buy |
676,678
+464,178
| +218% | +$9.89M | 0.16% | 191 |
|
|
2022
Q1 | $4.09M | Buy |
+212,500
| New | +$4.09M | 0.04% | 271 |
|